Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeMarathon Medical Inc.Marathon Medical wins inclusion of the geko™ device on its Veterans Administration Federal Supply Schedule Contract

Marathon Medical wins inclusion of the geko™ device on its Veterans Administration Federal Supply Schedule Contract

Marathon Medical Inc. is a distribution partner to Sky Medical Technology.

The wearable, clinically proven geko™ is a small, battery powered, disposable, neuromuscular electro-stimulation device, that is applied non-invasively to the skin over the common peroneal nerve at the side of the knee. Small electrical pulses gently stimulates the nerve, once every second, activating the calf and foot muscle pumps resulting in increased blood flow in the deep veins of the calf, at rate equal to 60% of continuous walking without the patient having to move. The increase in blood flow prevents venous thromboembolism (VTE – blood clots)[3], reduces pre-operative trauma-based swelling and prevents and treats the build-up of post-operative swelling.

The Contract award number #36F79718D0321 enables the VA and other federal organizations to purchase the FDA-cleared geko™ device at pre-approved pricing via the Marathon Medical Federal Supply Schedule (FSS) contract, or via the GSA Advantage Online Catalog. Additionally the Department of Defense has included the product on DAPA contract number #SP0200-13-H-0003.

“Adding the geko™ device to our supply schedule to help the VA hospitals prevent Venous Thromboembolism (VTE) and manage post-operative and trauma-based swelling, makes perfect sense,” says Jon Landis, COO, Marathon Medical. “Blood clots affect more than 900,000 American citizens each year, and 3 in 10 people who suffer a blood clot will have another episode within 10 years. Edema, the medical term for swelling, a huge and until now more silent burden, with few tools to address the complication, can delay surgical fixation, impede wound closure, decrease muscle strength and stall rehabilitation. We are therefore extremely proud to provide federally-operated hospitals access to an innovation that can help address these significant medical challenges.”

“We share in this excitement,” says Bernard Ross, Sky Founder and CEO. “The VA is the largest Integrated health network in the USA, treating in excess of 9 million veterans annually, at 171 VA hospitals and 1,454 health care facilities. We plan to serve this health system alongside Marathon to grow geko™ device awareness and market access. Our partnership with Marathon and the inclusion of the geko™ device on the FSS contract, enables our commitment to help those who serve and have served their country and their families. It is our hope that that we can make a positive impact on the lives of veterans to prevent life threatening blood clots and to manage swelling complications related to surgery and trauma.”

  • To increase local blood circulation.
  • For immediate post-surgical stimulation of the calf muscles to prevent venous thrombosis.
  • Stimulation of the calf muscles to prevent venous thrombosis in non-surgical patients at risk for venous thromboembolism.
  • For the reduction of edema.

In the USA the geko™ device is cleared for the following indications:

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy